Up 103% from 52-week low, this largecap pharma stock is double upgraded by Jefferies to 'buy'
Zydus Lifesciences traded with gains after Jefferies double upgraded the counter.
Shares of Zydus Lifesciences will gain traction in Wednesday's trade (August 28) as global brokerage firm Jefferies double upgrades the largecap pharma stock. In the pre-opening session, the stock was up over 2 per cent at Rs 1,147.05 per share.
At the last count, at around 10:01 am, shares traded higher by around 2 per cent at Rs 1,132.55, while at the day's high it gained up to 4 per cent to Rs1,156.45. The stock's 52-week high and low prices are Rs 1,323.9 and Rs 567.85 per share, respectively.
What Jefferies make of Zydus Lifesciences stock?
Jefferies has double upgraded the stock to a 'buy' from the earlier 'hold' call and a raised target price of Rs 1,450 from the earlier target of Rs 1,210, implying substantial gains of over 30 per cent.
The global brokerage held that the current correction in the stock offers a good entry opportunity in the stock. The stock in 1-week has tumbled over 5 per cent, while in the last 1-month has fallen over 6 per cent.
The rationale for a buy is also given the company's strong product pipeline. The pharma leader intends to make $8- 10 crore launch every year.
Also, the brokerage expects the company's India market to record better sales and margins amid better growth opportunities. In view of all this, the brokerage expects the company to outperform the pharma space.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
Top Gold ETF vs Top Large Cap Mutual Fund 10-year Return Calculator: Which has given higher return on Rs 11 lakh investment; see calculations
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
10:53 AM IST